Human Molecular Genetics, 2000, Vol. 9, No. 4 467-475
© 2000 Oxford University Press
Decreased aminoacylation of mutant tRNAs in MELAS but not in MERRF patients
1Max-Planck-Institute for Evolutionary Anthropology, Inselstrasse 22, D-04103 Leipzig, Germany, 2Department of Molecular and Cellular Biology, Harvard University, 7 Divinity Avenue, Cambridge, MA 02138, USA, 3Istituto Nazionale Neurologico Carlo Besta, Divisione di Biochemica e Genetica, Via Celoria 11, I-20133 Milano, Italy, 4Institutes for Clinical Chemistry and Diabetes Research, Academic Hospital Schwabing, D-80804 Munich, Germany, 5Friedrich Baur Institut, University of Munich, Ziemsenstrasse 1a, D-80336 Munich, Germany, 6Department of Neurology, Klinikum Großhadern, University of Munich, D-82366 Munich, Germany, 7Department of Neuroscience, Neurology, University Hospital, S-751 85 Uppsala, Sweden and 8Department of Clinical Chemistry, Sahlgrenska University Hospital, S-413 45 Göteborg, Sweden
Mutations in human mitochondrial tRNA genes are associated with a number of multisystemic disorders. Using an assay that combines tRNA oxidation and circularization we have determined the relative amounts and states of aminoacylation of mutant and wild-type tRNAs in tissue samples from patients with MELAS syndrome (mito- chondrial myopathy, encephalopathy, lactic acidosis, stroke-like episodes) and MERRF syndrome (myoclonus epilepsy with ragged red fibers), respectively. In most, but not all, biopsies from MELAS patients carrying the A3243G substitution in the mitochondrial tRNALeu(UUR) gene, the mutant tRNA is under-represented among processed and/or aminoacylated tRNAs. In contrast, in biopsies from MERRF patients harboring the A8344G substitution in the tRNALys gene neither the relative abundance nor the aminoacylation of the mutated tRNA is affected. Thus, whereas the A3243G mutation may contribute to the pathogenesis of MELAS by reducing the amount of aminoacylated tRNALeu, the A8344G mutation does not affect tRNALys function in the same way.
+ To whom correspondence should be addressed. Tel: +1 617 495 4396; Fax: +1 617 495 0758; Email: boerner@fas.harvard.edu
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. Park, E. Davidson, and M. P. King Overexpressed mitochondrial leucyl-tRNA synthetase suppresses the A3243G mutation in the mitochondrial tRNALeu(UUR) gene RNA, November 1, 2008; 14(11): 2407 - 2416. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M.C. Janssen, P. J. Hensbergen, F. J. van Bussel, C. I.A. Balog, J. A. Maassen, A. M. Deelder, and A. K. Raap The A3243G tRNALeu(UUR) mutation induces mitochondrial dysfunction and variable disease expression without dominant negative acting translational defects in complex IV subunits at UUR codons Hum. Mol. Genet., October 15, 2007; 16(20): 2472 - 2481. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ling, H. Roy, D. Qin, M. A. T. Rubio, J. D. Alfonzo, K. Fredrick, and M. Ibba Pathogenic mechanism of a human mitochondrial tRNAPhe mutation associated with myoclonic epilepsy with ragged red fibers syndrome PNAS, September 25, 2007; 104(39): 15299 - 15304. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Maniura-Weber, M. Helm, K. Engemann, S. Eckertz, M. Mollers, M. Schauen, A. Hayrapetyan, J.-C. von Kleist-Retzow, R. N. Lightowlers, L. A. Bindoff, et al. Molecular dysfunction associated with the human mitochondrial 3302A>G mutation in the MTTL1 (mt-tRNALeu(UUR)) gene Nucleic Acids Res., December 2, 2006; 34(22): 6404 - 6415. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. ROY, L. M. WITTENHAGEN, and S. O. KELLEY Structural probing of a pathogenic tRNA dimer RNA, March 1, 2005; 11(3): 254 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Levinger, M. Morl, and C. Florentz Mitochondrial tRNA 3' end metabolism and human disease Nucleic Acids Res., October 11, 2004; 32(18): 5430 - 5441. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. SISSLER, M. HELM, M. FRUGIER, R. GIEGE, and C. FLORENTZ Aminoacylation properties of pathology-related human mitochondrial tRNALys variants RNA, May 1, 2004; 10(5): 841 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Joseph, A. A. Rungi, B. H. Robinson, and D. A. Hood Compensatory responses of protein import and transcription factor expression in mitochondrial DNA defects Am J Physiol Cell Physiol, April 1, 2004; 286(4): C867 - C875. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Maassen, Leen. M. 't Hart, E. van Essen, R. J. Heine, G. Nijpels, R. S. Jahangir Tafrechi, A. K. Raap, G. M.C. Janssen, and H. H.P.J. Lemkes Mitochondrial Diabetes: Molecular Mechanisms and Clinical Presentation Diabetes, February 1, 2004; 53(90001): S103 - 109. [Abstract] [Full Text] |
||||
![]() |
H. T. Jacobs Disorders of mitochondrial protein synthesis Hum. Mol. Genet., October 15, 2003; 12(90002): R293 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Toompuu, T. Yasukawa, T. Suzuki, T. Hakkinen, J. N. Spelbrink, K. Watanabe, and H. T. Jacobs The 7472insC Mitochondrial DNA Mutation Impairs the Synthesis and Extent of Aminoacylation of tRNASer(UCN) but Not Its Structure or Rate of Turnover J. Biol. Chem., June 14, 2002; 277(25): 22240 - 22250. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Karadimas, K. Tanji, M. Geremek, P. Chronopoulou, T. Vu, S. Krishna, C. M. Sue, S. Shanske, E. Bonilla, S. DiMauro, et al. A5814G Mutation in Mitochondrial DNA Can Cause Mitochondrial Myopathy and Cardiomyopathy J Child Neurol, July 1, 2001; 16(7): 531 - 533. [Abstract] [PDF] |
||||
![]() |
H. T. Jacobs and I. J. Holt The np 3243 MELAS mutation: damned if you aminoacylate, damned if you don't Hum. Mol. Genet., March 1, 2000; 9(4): 463 - 465. [Abstract] [Full Text] [PDF] |
||||







